Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 25.56
(1.43%)
CNY 25.56
(1.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 818.96 Million CNY | 10.59% |
| 2022 | 740.56 Million CNY | 5.19% |
| 2021 | 704.02 Million CNY | -6.05% |
| 2020 | 749.39 Million CNY | -25.67% |
| 2019 | 1 Billion CNY | 3.72% |
| 2018 | 972.11 Million CNY | 78.17% |
| 2017 | 545.6 Million CNY | 77.12% |
| 2016 | 308.04 Million CNY | -22.0% |
| 2015 | 394.92 Million CNY | -22.4% |
| 2014 | 508.91 Million CNY | -10.5% |
| 2013 | 568.59 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 178.46 Million CNY | 0.96% |
| 2024 Q1 | 176.77 Million CNY | 2.69% |
| 2024 Q3 | 213.22 Million CNY | 19.48% |
| 2023 FY | 818.96 Million CNY | 10.59% |
| 2023 Q3 | 243.46 Million CNY | -4.84% |
| 2023 Q2 | 255.83 Million CNY | 73.43% |
| 2023 Q1 | 147.51 Million CNY | -38.03% |
| 2023 Q4 | 172.15 Million CNY | -29.29% |
| 2022 Q2 | 182.42 Million CNY | 35.2% |
| 2022 Q1 | 134.93 Million CNY | -27.33% |
| 2022 FY | 740.56 Million CNY | 5.19% |
| 2022 Q4 | 238.05 Million CNY | 28.57% |
| 2022 Q3 | 185.15 Million CNY | 1.49% |
| 2021 Q2 | 206.84 Million CNY | 6.73% |
| 2021 Q1 | 193.79 Million CNY | -18.62% |
| 2021 Q3 | 117.72 Million CNY | -43.09% |
| 2021 Q4 | 185.66 Million CNY | 57.72% |
| 2021 FY | 704.02 Million CNY | -6.05% |
| 2020 FY | 749.39 Million CNY | -25.67% |
| 2020 Q4 | 238.14 Million CNY | 27.63% |
| 2020 Q2 | 259.84 Million CNY | 300.91% |
| 2020 Q1 | 64.81 Million CNY | -77.41% |
| 2020 Q3 | 186.58 Million CNY | -28.19% |
| 2019 Q3 | 205.33 Million CNY | -38.29% |
| 2019 Q1 | 183.31 Million CNY | -41.08% |
| 2019 FY | 1 Billion CNY | 3.72% |
| 2019 Q4 | 286.89 Million CNY | 39.72% |
| 2019 Q2 | 332.72 Million CNY | 81.51% |
| 2018 Q2 | 289.09 Million CNY | 66.37% |
| 2018 FY | 972.11 Million CNY | 78.17% |
| 2018 Q4 | 311.09 Million CNY | 56.99% |
| 2018 Q3 | 198.17 Million CNY | -31.45% |
| 2018 Q1 | 173.75 Million CNY | -7.91% |
| 2017 FY | 545.6 Million CNY | 77.12% |
| 2017 Q3 | 124.38 Million CNY | 0.0% |
| 2017 Q4 | 188.67 Million CNY | 51.69% |
| 2016 FY | 308.04 Million CNY | -22.0% |
| 2015 FY | 394.92 Million CNY | -22.4% |
| 2014 FY | 508.91 Million CNY | -10.5% |
| 2013 FY | 568.59 Million CNY | 0.0% |